Internal Medicine, Hematology & Oncology · Frankfort, KY
NPI
1942284799
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
617 Chamberlin Ave
Frankfort, KY, 40601
Phone (502) 699-2285
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
114,783 services
Medicare patients, 2024
262
Average age 73
Drug cost, 2024
$3.8M
2,065 prescriptions
Company payments, 2025
$671
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rickey C Myhand was code J1453 (injection, fosaprepitant, 1 mg), 26,400 times for 20 patients. In total Rickey C Myhand billed 114,783 services in 92 codes, and Medicare paid $1.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1453 Injection, fosaprepitant, 1 mg | Office | 26,400 | 20 | $0.11 | $2,938 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,400 | 35 | $0.09 | $301 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 2,230 | 23 | $0.68 | $1,513 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,116 | 22 | $0.07 | $81.68 |
| 96375 Injection Administration | Office | 767 | 44 | $10.73 | $8,232 |
| 99214 Office E&M - Established | Office | 598 | 142 | $88.07 | $53K |
| 96413 Chemotherapy Administration | Office | 386 | 42 | $86.29 | $33K |
| 96367 Intravenous Infusion, Hydration | Office | 245 | 27 | $19.29 | $4,726 |
| 99213 Office E&M - Established | Office | 181 | 110 | $52.97 | $9,588 |
| 96372 Injection Administration | Office | 179 | 25 | $10.26 | $1,837 |
| 99232 Hospital E&M - Subsequent | Facility | 171 | 43 | $58.65 | $10K |
| 99215 Office E&M - Established | Office | 149 | 31 | $122.77 | $18K |
| 96417 Chemotherapy Administration | Office | 115 | 16 | $44.35 | $5,100 |
| 96415 Chemotherapy Administration | Office | 101 | 16 | $18.21 | $1,839 |
| 96411 Chemotherapy Administration | Office | 100 | 13 | $35.57 | $3,557 |
By year: 2022 $1.4M for 118,537 services; 2023 $1.5M for 92,429 services; 2024 $1.7M for 114,783 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rickey C Myhand prescribed most often to Medicare patients was Letrozole, with 119 prescriptions and refills. In total Rickey C Myhand wrote 2,065 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 119 | 238 | 34 | $2,074 |
| Mirtazapine Generic | 102 | 133 | 37 | $997 |
| Eliquis Apixaban | 80 | 95 | 23 | $54K |
| Oxycodone Hcl Generic | 70 | 70 | 15 | $616 |
| Prednisone Generic | 68 | 77 | 29 | $303 |
| Ondansetron Odt Ondansetron | 55 | 55 | 36 | $1,206 |
| Anastrozole Generic | 53 | 130 | 21 | $1,155 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 50 | 50 | 18 | $380 |
| Gabapentin Generic | 45 | 46 | Under 11 | $210 |
| Keytruda Pembrolizumab | 43 | 43 | Under 11 | $470K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 42 | 42 | 12 | $423 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 41 | 43 | 34 | $451 |
| Citalopram Hbr Citalopram Hydrobromide | 34 | 48 | Under 11 | $350 |
| Ibrance Palbociclib | 34 | 34 | Under 11 | $528K |
| Doxycycline Hyclate Generic | 34 | 34 | 24 | $259 |
Brand drugs: 553 claims; generic drugs: 1,512 claims; opioid claims: 256.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rickey C Myhand $671 ($671 in general payments such as food, travel and fees) from 25 companies. The largest payer was Geron Corporation with $56.52.
| Company | Payments | Amount |
|---|---|---|
| Geron Corporation GERN | 2 | $56.52 |
| Octapharma USA, Inc. | 2 | $49.56 |
| Astellas Pharma US Inc 4503.T | 2 | $40.13 |
| Celgene Corporation BMY | 2 | $35.5 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $34.59 |
| TerSera Therapeutics LLC | 1 | $33.97 |
| Eisai Inc. 4523.T | 2 | $32.13 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $27.99 |
| Gilead Sciences, Inc. GILD | 2 | $27.98 |
| Incyte Corporation INCY | 1 | $27.67 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.